General Information of the Compound
| Compound ID |
CP0335636
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-methyl-2-[(5S)-2-[4-(piperidine-1-carbonyl)phenyl]-5H-chromeno[2,3-b]pyridin-5-yl]-N-(1,3,4-thiadiazol-2-yl)propanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H29N5O3S
|
||||||||||||||||||
| Molecular Weight |
539.661
|
||||||||||||||||||
| Canonical SMILES |
CC(C)([C@H]1c2ccccc2Oc2nc(ccc12)-c1ccc(cc1)C(=O)N1CCCCC1)C(=O)Nc1nncs1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H29N5O3S/c1-30(2,28(37)33-29-34-31-18-39-29)25-21-8-4-5-9-24(21)38-26-22(25)14-15-23(32-26)19-10-12-20(13-11-19)27(36)35-16-6-3-7-17-35/h4-5,8-15,18,25H,3,6-7,16-17H2,1-2H3,(H,33,34,37)/t25-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
PWEMFMRMUURTCW-VWLOTQADSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00967, Glucocorticoid receptor
Cell-based Assay